Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
Principal U.S. Small Cap Index ETF | PSC | 24. dec 2024 | 52.04 | +0.93 |
Priority Income Fund | PRIF-L | 24. dec 2024 | 23.37 | -1.68 |
Priority Income Fund | PRIF-K | 24. dec 2024 | 21.51 | +1.42 |
Priority Income Fund D Pref | PRIF-D | 24. dec 2024 | 24.15 | -1.43 |
Priority Income Fund F Pref | PRIF-F | 24. dec 2024 | 24.24 | -1.78 |
Priority Income Fund G Pref | PRIF-G | 24. dec 2024 | 25.34 | 0.00 |
Priority Income Fund I Pref | PRIF-I | 24. dec 2024 | 23.17 | -0.61 |
Priority Income Fund J Pref | PRIF-J | 24. dec 2024 | 22.85 | -0.35 |
Priority Income Fund Pref | PRIF-H | 24. dec 2024 | 24.04 | -0.87 |
Priority Technology | PRTH | 24. dec 2024 | 10.83 | +17.46 |
Privia Health Group | PRVA | 24. dec 2024 | 19.90 | -0.05 |
Pro-Dex | PDEX | 24. dec 2024 | 48.13 | +4.86 |
ProAssurance | PRA | 24. dec 2024 | 16.07 | +1.32 |
Procaps Group | PROC | 24. dec 2024 | 2.48 | -6.06 |
Procept BioRobotics | PRCT | 24. dec 2024 | 83.72 | +3.17 |
Processa Pharmaceuticals | PCSA | 24. dec 2024 | 0.87 | +4.04 |
Procore Technologies | PCOR | 24. dec 2024 | 77.79 | +1.63 |
Procter & Gamble | PG | 24. dec 2024 | 168.94 | +0.49 |
Professional Diversity Network | IPDN | 24. dec 2024 | 0.41 | -0.44 |
Proficient Auto Logistics | PAL | 24. dec 2024 | 7.84 | +2.08 |
Profire Energy | PFIE | 24. dec 2024 | 2.54 | +0.79 |
Profound Medical | PROF | 24. dec 2024 | 6.98 | -0.29 |
ProFrac A | ACDC | 24. dec 2024 | 7.35 | +2.37 |
PROG | PRG | 24. dec 2024 | 42.51 | +1.87 |
Progress Software | PRGS | 24. dec 2024 | 66.26 | +1.49 |
Progressive | PGR | 24. dec 2024 | 243.24 | +0.93 |
Progyny | PGNY | 24. dec 2024 | 14.53 | +0.28 |
ProKidney | PROK | 24. dec 2024 | 1.78 | +5.33 |
Prologis | PLD | 24. dec 2024 | 104.70 | +0.54 |
ProMIS Neurosciences | PMN | 24. dec 2024 | 0.91 | -1.63 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.